CN112159552B - 一种海藻多糖基磷酸银复合材料的制备方法 - Google Patents
一种海藻多糖基磷酸银复合材料的制备方法 Download PDFInfo
- Publication number
- CN112159552B CN112159552B CN202010989849.1A CN202010989849A CN112159552B CN 112159552 B CN112159552 B CN 112159552B CN 202010989849 A CN202010989849 A CN 202010989849A CN 112159552 B CN112159552 B CN 112159552B
- Authority
- CN
- China
- Prior art keywords
- solution
- composite material
- preparation
- phosphate
- seaweed polysaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229940019931 silver phosphate Drugs 0.000 title claims abstract description 50
- 229910000161 silver phosphate Inorganic materials 0.000 title claims abstract description 50
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 title claims abstract description 48
- 239000002131 composite material Substances 0.000 title claims abstract description 45
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 42
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 42
- 150000004676 glycans Chemical class 0.000 title claims abstract 12
- 238000002360 preparation method Methods 0.000 title claims description 24
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 40
- 241001474374 Blennius Species 0.000 claims abstract description 40
- 239000000661 sodium alginate Substances 0.000 claims abstract description 40
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 40
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 40
- 238000004132 cross linking Methods 0.000 claims abstract description 11
- 238000000465 moulding Methods 0.000 claims abstract description 8
- 229910002651 NO3 Inorganic materials 0.000 claims abstract description 4
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 96
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 68
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 39
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 34
- 239000008367 deionised water Substances 0.000 claims description 33
- 229910021641 deionized water Inorganic materials 0.000 claims description 33
- 238000003756 stirring Methods 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 239000010452 phosphate Substances 0.000 claims description 20
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 20
- 229910019142 PO4 Inorganic materials 0.000 claims description 19
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 17
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 17
- -1 halide salt Chemical class 0.000 claims description 9
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 claims description 7
- 230000009471 action Effects 0.000 claims description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- 159000000007 calcium salts Chemical class 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 5
- 229910001424 calcium ion Inorganic materials 0.000 claims description 5
- 238000002604 ultrasonography Methods 0.000 claims description 5
- 150000003751 zinc Chemical class 0.000 claims description 5
- 239000012266 salt solution Substances 0.000 claims description 4
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 3
- 150000004820 halides Chemical class 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 2
- 150000003863 ammonium salts Chemical class 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 21
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 14
- 238000000034 method Methods 0.000 abstract description 13
- 238000011065 in-situ storage Methods 0.000 abstract description 5
- 238000001035 drying Methods 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 239000012530 fluid Substances 0.000 abstract description 3
- 238000005406 washing Methods 0.000 abstract description 3
- 230000007547 defect Effects 0.000 abstract description 2
- 150000004804 polysaccharides Chemical class 0.000 description 30
- 239000000648 calcium alginate Substances 0.000 description 18
- 235000010410 calcium alginate Nutrition 0.000 description 18
- 229960002681 calcium alginate Drugs 0.000 description 18
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 17
- 235000021317 phosphate Nutrition 0.000 description 17
- 229910052760 oxygen Inorganic materials 0.000 description 14
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 13
- 239000001301 oxygen Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 11
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 description 10
- 239000003063 flame retardant Substances 0.000 description 10
- 239000000779 smoke Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 8
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 8
- 238000002485 combustion reaction Methods 0.000 description 7
- 229910052709 silver Inorganic materials 0.000 description 7
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000000017 hydrogel Substances 0.000 description 6
- 239000004332 silver Substances 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 241000195493 Cryptophyta Species 0.000 description 5
- 229920000615 alginic acid Polymers 0.000 description 5
- 229960005069 calcium Drugs 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- AMHXQVUODFNFGR-UHFFFAOYSA-K [Ag+3].[O-]P([O-])([O-])=O Chemical class [Ag+3].[O-]P([O-])([O-])=O AMHXQVUODFNFGR-UHFFFAOYSA-K 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 4
- 235000019799 monosodium phosphate Nutrition 0.000 description 4
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 4
- 229940072056 alginate Drugs 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000004254 Ammonium phosphate Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 238000003917 TEM image Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 2
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 2
- 235000019289 ammonium phosphates Nutrition 0.000 description 2
- 239000004566 building material Substances 0.000 description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 2
- 239000001527 calcium lactate Substances 0.000 description 2
- 229960002401 calcium lactate Drugs 0.000 description 2
- 235000011086 calcium lactate Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 150000003378 silver Chemical class 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 235000011008 sodium phosphates Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 239000004246 zinc acetate Substances 0.000 description 2
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001261506 Undaria pinnatifida Species 0.000 description 1
- CPGKMLVTFNUAHL-UHFFFAOYSA-N [Ca].[Ca] Chemical compound [Ca].[Ca] CPGKMLVTFNUAHL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012767 functional filler Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000009740 moulding (composite fabrication) Methods 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/32—Phosphorus-containing compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/26—Phosphorus; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/12—Chemical modification
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/04—Alginic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/32—Phosphorus-containing compounds
- C08K2003/321—Phosphates
- C08K2003/328—Phosphates of heavy metals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2201/00—Properties
- C08L2201/02—Flame or fire retardant/resistant
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Manufacturing & Machinery (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
本发明涉及复合材料技术领域,具体涉及一种海藻多糖基磷酸银复合材料的制备方法,以硝酸盐、海藻酸钠为原料,采用原位法生成海藻酸钠/磷酸银流体,再经成型、交联、净洗、蒸汽干燥制得海藻多糖基磷酸银复合材料,采用本发明方法制成的海藻多糖基磷酸银复合材料不仅弥补了海藻多糖材料不抗菌的缺陷,而且大幅度提高了复合材料的耐火性能和抗菌性能,特别适用于耐火和抗菌要求均较高的装饰材料。
Description
技术领域
本发明涉及复合材料技术领域,具体涉及一种海藻多糖基磷酸银复合材料的制备方法。
背景技术
我国年产海藻约790万吨,海带414万吨,裙带菜169万吨,约占世界总产量的80%以上,具有巨大的资源优势。目前对海藻的利用主要是直接用作食品,附加值很低。如何将这一资源优势转化为高附加值产业优势是我国蓝色经济中的重要目标之一。
海藻酸及其盐是无毒、可生物降解的海洋多糖高聚物。海藻酸钠具有生物相容性好、可生物降解、无毒副作用,以及优异的吸湿性能、凝胶性能和生物活性,被广泛应用于化学、生物、医药、食品,环保等领域。在已有的技术中,用海藻酸钠制备海藻酸钙纤维等阻燃材料,但海藻酸钙纤维或者材料在对耐火性能要求较高的场合,其阻燃性能还达不到要求,尤其是没有抗菌性能,从而限制了它在装饰材料、防火、防传染性疾病等领域的应用。
目前常用的抗菌剂包括银系抗菌剂,其抗菌机理主要如下:1)通过银离子与细菌的接触反应表现抗菌作用;2)通过光的催化反应形成活性极强的自由基引发抗菌能力;但抗菌剂往往被作用功能性填料添加,因此要求其符合制品的加工温度,进而对银系抗菌剂的耐热性要求较高。Ag3PO4作为一种高效可见光催化剂,光响应最大吸收波长可达530nm,小于420nm波长光照时光量子利用率达90%以上,在光解水、光催化污水处理、光催化抑菌等领域被进行了广泛研究。
Ag3PO4作为一种高效可见光催化剂,光响应最大吸收波长可达530nm,小于420nm波长光照时光量子利用率达90%以上,在光解水、光催化污水处理、光催化抑菌等领域被进行了广泛研究,但是磷酸银难以在许多材料的表面固定,易于大量释放银离子产生毒性等问题使得银盐的直接应用面临巨大的挑战,目前在聚合物材料上直接负载或原位合成纳米银引起了研究者的广泛兴趣,文献《海藻酸盐原位制备纳米银/海藻纤维及其性能研究》明确指出了海藻酸钠的羧基可与银离子通过静电相互作用形成复合物,分子链上的羟基具有还原性,可将Ag+还原为Ag,具体是在海藻酸钠溶液中加入适量的硝酸银,混合均匀,然后加入葡萄糖,继续搅拌混合均匀,边搅拌边加热到一定温度,加热一定时间后,迅速取出,立即冷却至室温;专利申请号2019111642508公开了一种含磷酸银的海藻酸钙抗菌水凝胶过滤膜的制备方法,包括以下步骤:a)配制质量百分比浓度0.1-20%的可溶性磷酸盐水溶液;b)配制质量百分比浓度0.1-20%的硝酸银水溶液;c)将步骤a)得到的可溶性磷酸盐水溶液滴加到步骤b)得到的硝酸银水溶液中直至可溶性磷酸盐过量,获得磷酸银和可溶性磷酸盐的混合物溶液,在此混合物溶液中溶解质量百分比浓度0.2-8%的海藻酸钠,静置脱泡得到铸膜液;d)配制质量百分比浓度0.2-20%的可溶性钙盐水溶液,作为凝固浴;e)将步骤c)得到的铸膜液倒在干燥清洁的玻璃板上,用两端缠绕直径为20-1500μm铜丝的玻璃棒刮平,然后立即将玻璃板和刮好的膜放入步骤d)得到的凝固浴中浸泡5-240min,可溶性钙盐与海藻酸钠反应生成海藻酸钙水凝胶的同时,在海藻酸钙水凝胶中与可溶性磷酸盐生成磷酸钙,且磷酸钙将磷酸银包裹起来避免了其在海藻酸钙水凝胶中的流失;磷酸钙盐与海藻酸盐通过钙离子交联生成有机无机杂化结构,再加上其物理增强作用,从而提高了海藻酸钙水凝胶的机械强度,降低了其溶胀率;f)最后用去离子水浸泡并反复洗涤除去膜中和膜表面残留的无机盐,得到含磷酸银的海藻酸钙抗菌水凝胶过滤膜。但银离子在载体上分布不均匀、分布密度低和稳定性差也制约了银盐的应用发展,尤其是直接将海藻酸盐与磷酸银反应,使得磷酸银在海藻多糖大分子上团聚、分布不匀,严重制约了复合材料的应用。
发明内容
本发明针对现有技术的不足,提出了一种海藻多糖基磷酸银复合材料的制备方法。
具体是通过以下技术方案来实现的:
一种海藻多糖基磷酸银复合材料的制备方法,以硝酸盐、海藻酸钠为原料,采用原位法生成海藻酸钠/磷酸银流体,再经成型、交联、净洗、蒸汽干燥制得海藻多糖基磷酸银复合材料。
一种海藻多糖基磷酸银复合材料的制备方法,包括如下步骤:
(1)分别将磷酸盐、海藻酸钠、去离子水按照1:2-4:70-100的质量比配成溶液A;
(2)分别将硝酸银、25%氨水、去离子水按照1:5-6:5-7的质量比配成溶液B;
(3)在搅拌下将溶液B滴加到溶液A中,待反应液变成金黄色时终止搅拌,并静置10-20min,即得溶液C;
(4)将溶液C在成型设备中成形后,置于质量浓度为1-3%可溶性非卤化物钙盐溶液中交联反应20-60min,用去离子水浸洗,再经95-103℃蒸汽干燥,冷至常温即为成品。
步骤(1)中,所述磷酸盐为水溶性钠盐、钾盐、铵盐。
所述成形是指板状、球粒状、条状、丝线状或膜状中任一种。
步骤(1)中,所述溶液A,其配制操作是:将磷酸盐溶于水中,调pH至9-10,然后将其加热到45℃,在超声作用下缓慢加入海藻酸钠,在海藻酸钠完全溶解后维持30-60min,即得。
步骤(2)中,所述溶液B,其配制操作是:将硝酸银在常温下溶解于水中,然后在搅拌下将25%氨水滴入硝酸银溶液中,再维持搅拌反应3-5min。
步骤(4)中,所述可溶性非卤化物盐为硝酸盐、醋酸盐、乳酸盐;优选,为钙盐、锌盐、钙盐和锌盐的混合物中任意一种。
所述可溶性非卤化物盐溶液,其用量以溶液中钙离子或锌离子计,钙离子或锌离子质量是海藻酸钠质量的8-15%。
步骤(4)中,所述交联反应,其温度为20-45℃。
步骤(3)中,所述溶液B与溶液A的用量比为溶液B中硝酸银与溶液A中磷酸盐为等摩尔比。
1.溶液A对海藻多糖基磷酸银复合材料的阻燃性能影响
本申请选择磷酸盐、海藻酸钠为溶液A的原料,以去离子水为溶剂,将磷酸盐、海藻酸钠、溶剂按照1:1:50(A1组)、1:1:70(A2组)、2:1:50(A3组)、1:2:100(A4组)、1:2:70(A5组)、1:4:70(A6组)、1:4:100(A7组)、1:5:70(A8组)、1:5:100(A9组)、1:4:50(A10组)的质量比进行配制,然后按照硝酸银和磷酸盐进行等摩尔比将溶液A、B混合,再按照实施例2的方法制成海藻多糖基磷酸银复合材料;
将各组复合材料按照国标《塑料燃烧性能实验方法氧指数法》(GB/T 2406—93)判断其防火性能,按照国标《建筑材料燃烧或分解的烟密度试验方法》(GB/T 8627—2007)进行排烟量的检测,其结果显示:A1组-A10组的氧指数均大于27,属于难燃材料,其中A4组-A7组(分布在55-68之间)的氧指数显著高于其他组别(分布在29-33范围内),而烟密度与其他组别相当,均小于300Dm,烟密度分布在90-100Dm范围内。
2.溶液B对海藻多糖基磷酸银复合材料的阻燃性能影响
本申请选择硝酸银、25%氨水为溶液B的原料,以去离子水为溶剂,将硝酸银、25%氨水、溶剂按照1:5:5(B1组)、1:6:5(B2组)、1:5:7(B3组)、1:6:7(B4组)、2:5:5(B5组)、2:8:5(B6组)、1:4:7(B7组)、1:5:9(B8组)的质量比进行配制,然后按照硝酸银和磷酸盐进行等摩尔比将溶液A、B混合,再按照实施例5的方法制成海藻多糖基磷酸银复合材料;
将各组复合材料按照国标《塑料燃烧性能实验方法氧指数法》(GB/T 2406—93)判断其防火性能,按照国标《建筑材料燃烧或分解的烟密度试验方法》(GB/T 8627—2007)进行排烟量的检测,其结果显示:B1组-B8组的氧指数均大于27,属于难燃材料,其中B1组-B4组(分布在62-67之间)的氧指数显著高于其他组别(分布在38-45范围内),而烟密度方面,B1-B4组烟密度分布于58-92Dm内,B5-B8组分布于99-150Dm内,均小于300Dm。
同时,本发明选择最优组(B4组)对其进行试验,将25%氨水替换为10%、15%、30%、50%、75%进行实现,结果发现,当浓度低于25%时氧指数变小,替换为10%氨水时氧指数为40.2,当浓度高于25%时发烟量变大,其中30%、50%、75%的发烟量分别为134、196、303Dm,而氧指数分比为53.2、62.7、57.4,但均低于B4组66.8。
有益效果:
(1)海藻多糖基磷酸银复合材料不仅弥补了海藻多糖材料不抗菌的缺陷,而且大幅度提高了复合材料的耐火性能和抗菌性能,氧指数超过了60%,抑菌率达到了98%,特别适用于耐火和抗菌要求均较高的装饰材料。
(2)相对于物理混合法,多价金属的海藻酸盐和磷酸银的原位生成-复合过程,使得磷酸银在大分子本体内分布均匀,均一性好,流体性能好,有利于便捷地制成各种形状的材料和涂层。
(3)可溶性非卤化物钙盐和锌盐的选用,解决了在有氯离子环境中不能生成磷酸银的瓶颈技术问题。
(4)蒸汽干燥消除了材料的内应力,克服了材料的脆性,使材料有良好的弹性。当蒸汽温度低于95℃时,由于温度过低不能消除内应力;当蒸汽温度高于103℃时,温度过高,易造成复合材料抑菌活性下降。
附图说明
图1是海藻多糖基磷酸银复合材料的XPS图;
图2是海藻多糖基磷酸银复合材料的TEM显微照片;
图3是海藻多糖基磷酸银复合材料与海藻酸钙的TG曲线对比图;
图4是海藻多糖基磷酸银复合材料与海藻酸钙的对金黄色葡萄球菌抑菌圈对比图。
具体实施方式
下面对本发明的具体实施方式作进一步详细的说明,但本发明并不局限于这些实施方式,任何在本实施例基本精神上的改进或代替,仍属于本发明权利要求所要求保护的范围。
实施例1
一种海藻多糖基磷酸银复合材料的制备方法,包括如下步骤:
(1)按照磷酸二氢钠:海藻酸钠:去离子水=1:3:80的质量比进行称量,将磷酸二氢钠溶于去离子水中,用1%氢氧化钠溶液调节pH至9-10,然后加热至45℃,在超声作用下缓慢加入海藻酸钠,在海藻酸钠完全溶解后,维持30min,即得溶液A;
(2)称取与磷酸盐等摩尔的硝酸银,再按照硝酸银:25%氨水:去离子水=1:5:5的质量比进行称量,将硝酸银在常温下溶解于去离子水中,然后在搅拌下将25%氨水滴入硝酸银溶液中,再维持搅拌、反应3min,即得溶液B;
(3)在搅拌下将溶液B滴入溶液A中,待反应液变成金黄色时终止搅拌,并静置10min,即得溶液C;
(4)将溶液C在成型设备中成形为1mm的膜后,置于1%的硝酸钙溶液中45℃交联反应60min,其中,1%的硝酸钙溶液的用量以钙计钙质量是海藻酸钠质量的8%,再用去离子水浸洗,再100℃蒸汽干燥,冷却至常温即为成品。
实施例2
一种海藻多糖基磷酸银复合材料的制备方法,包括如下步骤:
(1)按照磷酸一氢钠:海藻酸钠:去离子水=1:3:85的质量比进行称量,将磷酸一氢钠溶于去离子水中,用1%氢氧化钠溶液调节pH至9-10,然后加热至45℃,在超声作用下缓慢加入海藻酸钠,在海藻酸钠完全溶解后,维持45min,即得溶液A;
(2)称取与磷酸盐等摩尔的硝酸银,再按照硝酸银:25%氨水:去离子水按照1:5.5:6的质量比进行称量,将硝酸银在常温下溶解于去离子水中,然后在搅拌下将25%氨水滴入硝酸银溶液中,再维持搅拌、反应4min,即得溶液B;
(3)在搅拌下将溶液B滴入溶液A中,待反应液变成金黄色时终止搅拌,并静置15min,即得溶液C;
(4)将溶液C在成型设备中成形为直径为1mm的丝线后,置于1%的硝酸锌溶液中30℃交联反应45min,其中,1%的硝酸锌溶液的用量以锌计,锌质量是海藻酸钠质量的10%,再用去离子水浸洗,再100℃蒸汽干燥,冷却至常温即为成品。
实施例3
一种海藻多糖基磷酸银复合材料的制备方法,包括如下步骤:
(1)按照磷酸钠:海藻酸钠:去离子水=1:4:100的质量比进行称量,将磷酸钠溶于去离子水中,用1%硝酸溶液调节pH至9-10,然后加热至45℃,在超声作用下缓慢加入海藻酸钠,在海藻酸钠完全溶解后,维持60min,即得溶液A;
(2)称取与磷酸盐等摩尔的硝酸银,再按照硝酸银:25%氨水:去离子水=1:6:7的质量比进行称量,将硝酸银在常温下溶解于去离子水中,然后在搅拌下将25%氨水滴入硝酸银溶液中,再维持搅拌、反应5min,即得溶液B;
(3)在搅拌下将溶液B滴入溶液A中,待到反应液变成金黄色时终止搅拌,并静置20min,即得溶液C;
(4)将溶液C在成型设备中成形为直径为3mm的球体后,置于3%的乳酸钙溶液中20℃交联反应30min,其中,3%的乳酸钙溶液的用量以钙计钙质量是海藻酸钠质量的15%,再用去离子水浸洗,再103℃蒸汽干燥,冷却至常温即为成品。
实施例4
一种海藻多糖基磷酸银复合材料的制备方法,包括如下步骤:
(1)按照磷酸铵:海藻酸钠:去离子水=1:4:100的质量比进行称量,将磷酸铵溶于去离子水中,用1%硝酸溶液调节pH至9-10,然后加热至45℃,在超声作用下缓慢加入海藻酸钠,在海藻酸钠完全溶解后,维持60min,即得溶液A;
(2)称取与磷酸盐等摩尔的硝酸银,再按照硝酸银:25%氨水:去离子水=1:6:7的质量比进行称量,将硝酸银在常温下溶解于去离子水中,然后在搅拌下将25%氨水滴入硝酸银溶液中,再维持搅拌、反应5min,即得溶液B;
(3)在搅拌下将溶液B滴入溶液A中,待反应液变成金黄色时终止搅拌,并静置20min,即得溶液C;
(4)将溶液C在成型设备中成形为厚度为5mm的板体后,置于3%的醋酸锌溶液中25℃交联反应20min,其中,3%的醋酸锌溶液的用量以锌计,锌质量是海藻酸钠质量的12%,再用去离子水浸洗,再95℃蒸汽干燥,冷却至常温即为成品。
实施例5
一种海藻多糖基磷酸银复合材料的制备方法,包括如下步骤:
(1)按照磷酸二氢钠:海藻酸钠:去离子水=1:3:85的质量比进行称量,将磷酸二氢钠溶于水中,用1%氢氧化钠溶液调节pH至9-10,然后加热至45℃,在超声作用下缓慢加入海藻酸钠,在海藻酸钠完全溶解后,维持45min,即得溶液A;
(2)称取与磷酸盐等摩尔的硝酸银,再按照硝酸银:25%氨水:去离子水=1:5.5:6的质量比进行称量,将硝酸银在常温下溶解于去离子水中,然后在搅拌下将25%氨水滴入硝酸银溶液中,再维持搅拌、反应4min,即得溶液B;
(3)在搅拌下将溶液B滴入溶液A中,待反应液变成金黄色时终止搅拌,并静置15min,即得溶液C;
(4)将溶液C在成型设备中成形为直径为5mm的条线后,置于1%的硝酸锌和1%硝酸钙混合溶液中25℃交联反应20min,其中1%硝酸钙的用量以钙计钙质量是海藻酸钠质量的6%,1%的硝酸锌的用量以锌计锌质量是海藻酸钠质量的6%,再用去离子水浸洗,再100℃蒸汽干燥,冷却至常温即为成品。
附图1是海藻多糖基磷酸银复合材料的XPS图,图1a是XPS总图,尤其可见所制备的材料中包含C、O、Ca、P、Ag元素。图1b在368.4和374.3eV处分别对应Ag3d5/2和Ag3d3/2的特征峰,表明Ag元素是以Ag+形式存在,来自Ag3PO4;检测条件:测试仪器:美国Thermo FisherScientific公司的ESCALAB 250Xi型号的X射线光电子能谱仪,采用Al靶,粉末状态样品。
附图2是海藻多糖基磷酸银复合材料的TEM显微照片,可以看到磷酸银为5-20纳米的球形,彼此远离,没有团聚现象。证明了复合材料为纳米复合材料,本制备方法避免了添加磷酸银易于团聚的弊端;检测条件:测试仪器:日本JEF 2100F场发射透射电子显微镜,粉末状态样品。
附图3是海藻多糖基磷酸银复合材料与海藻酸钙的TG曲线对比图。由此可见,海藻多糖基磷酸银复合材料分解过程与海藻酸钙相近,但前者的降解速率低于后者,而且前者的残渣量比后者多20%,这说明了复合材料比海藻酸钙阻燃性优异;检测条件:测试仪器:TAQ600同步热分析仪;测试条件:升温速率为10℃/min,升温范围为室温到900℃,氮气流速为100mL/min;粉末状态样品。
附图4是海藻多糖基磷酸银复合材料与海藻酸钙的对金黄色葡萄球菌抑菌圈对比图。由此可见,海藻酸钙(a)没有明显的抑菌圈,而海藻多糖基磷酸银复合材料则有明显的抑菌圈。测试仪器:立式压力蒸汽灭菌器,HWS智能型恒温恒湿培养箱,ZHJH-C1112B型超净工作台;测试方法:滤纸片法(通过将材料放置在蒸馏水中进行离心,并将滤纸片放置于其中使其充分吸收液体中溶解的部分材料,最后在测试前沥干将其放置于培养皿中,并在37℃恒温培养箱中培养24h)。
表1.海藻酸钙和海藻多糖基磷酸银复合材料的阻燃数据对比
表1为海藻酸钙和实施例1的海藻多糖基磷酸银复合材料的阻燃数据对比。垂直燃烧实验阻燃材料级别(UL-94)由垂直燃烧试验仪测试;极限氧指数(LOI)由极限氧指数仪测定;释热速率(PHRR)等燃烧实验数据由圆锥量热仪(CONE)测定。通过比较发现,尽管两者均达到UL-94标准中的V-0阻燃等级,但本专利申请实施例样品极限氧指数超过了61%,点燃时间更长,耐火性能得到显著提高。而且实施例样品的热释放速率、总热释放量和总释烟量都显著低于海藻酸钙材料,所以,复合材料在火灾中的安全性优势明显;检测条件:测试仪器:Dual Analysis Cone Calorimeter锥形量热仪,热流量为35kW/m2,根据ISO 5660,其样品尺寸为10cm×10cm×3cm。
Claims (7)
1.一种海藻多糖基磷酸银复合材料的制备方法,其特征在于,包括如下步骤:
(1)分别将磷酸盐、海藻酸钠、去离子水按照1:2-4:70-100的质量比配成溶液A;
(2)分别将硝酸银、25%氨水、去离子水按照1:5-6:5-7的质量比配成溶液B;
(3)在搅拌下将溶液B滴加到溶液A中,待反应液变成金黄色时终止搅拌,并静置10-20min,即得溶液C;
(4)将溶液C在成型设备中成形后,置于质量浓度为1-3%可溶性非卤化物盐溶液中交联反应20-60min,用去离子水浸洗,再经95-103℃蒸汽干燥,冷至常温即为成品;
步骤(4)中,所述交联反应,其温度为20-45℃。
2.如权利要求1所述一种海藻多糖基磷酸银复合材料的制备方法,其特征在于,步骤(1)中,所述溶液A,其配制操作是:将磷酸盐溶于水中,调pH至9-10,然后将其加热到45℃,在超声作用下缓慢加入海藻酸钠,在海藻酸钠完全溶解后维持30-60min,即得。
3.如权利要求1所述一种海藻多糖基磷酸银复合材料的制备方法,其特征在于,步骤(1)中,所述磷酸盐为水溶性钠盐、钾盐、铵盐。
4.如权利要求1所述一种海藻多糖基磷酸银复合材料的制备方法,其特征在于,步骤(2)中,所述溶液B,其配制操作是:将硝酸银在常温下溶解于水中,然后在搅拌下将25%氨水滴入硝酸银溶液中,再维持搅拌反应3-5min。
5.如权利要求1所述一种海藻多糖基磷酸银复合材料的制备方法,其特征在于,步骤(4)中,所述可溶性非卤化物盐为硝酸盐、醋酸盐、乳酸盐;所述可溶性非卤化物盐为钙盐、锌盐、钙盐和锌盐的混合物中任意一种。
6.如权利要求5所述一种海藻多糖基磷酸银复合材料的制备方法,其特征在于,所述可溶性非卤化物盐溶液,其用量以溶液中钙离子或锌离子计,钙离子或锌离子质量是海藻酸钠质量的8-15%。
7.如权利要求1所述一种海藻多糖基磷酸银复合材料的制备方法,其特征在于,步骤(3)中,所述溶液B与溶液A的用量比为溶液B中硝酸银与溶液A中磷酸盐为等摩尔比。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010989849.1A CN112159552B (zh) | 2020-09-18 | 2020-09-18 | 一种海藻多糖基磷酸银复合材料的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010989849.1A CN112159552B (zh) | 2020-09-18 | 2020-09-18 | 一种海藻多糖基磷酸银复合材料的制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112159552A CN112159552A (zh) | 2021-01-01 |
| CN112159552B true CN112159552B (zh) | 2022-05-24 |
Family
ID=73862474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010989849.1A Active CN112159552B (zh) | 2020-09-18 | 2020-09-18 | 一种海藻多糖基磷酸银复合材料的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112159552B (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6638917B1 (en) * | 2000-02-25 | 2003-10-28 | Scimed Life Systems, Inc. | Reducing adhesion |
| CN101463145A (zh) * | 2009-01-12 | 2009-06-24 | 武汉理工大学 | 羧甲基壳聚糖/氧化海藻酸钠自交联抗菌水凝胶材料 |
| CN103301860A (zh) * | 2013-06-09 | 2013-09-18 | 常州大学 | 多壁碳纳米管负载磷酸银可见光光催化剂的制备方法 |
| CN110563990A (zh) * | 2019-09-17 | 2019-12-13 | 广西科技大学 | 具有光降解功能的含银纤维素复合材料的制备方法及其应用 |
| CN110743397A (zh) * | 2019-11-26 | 2020-02-04 | 天津工业大学 | 一种含磷酸银的海藻酸钙抗菌水凝胶过滤膜的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10926000B2 (en) * | 2016-05-13 | 2021-02-23 | Colorado School Of Mines | Deposition-conversion method for tunable calcium phosphate coatings on substrates and apparatus prepared thereof |
-
2020
- 2020-09-18 CN CN202010989849.1A patent/CN112159552B/zh active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6638917B1 (en) * | 2000-02-25 | 2003-10-28 | Scimed Life Systems, Inc. | Reducing adhesion |
| CN101463145A (zh) * | 2009-01-12 | 2009-06-24 | 武汉理工大学 | 羧甲基壳聚糖/氧化海藻酸钠自交联抗菌水凝胶材料 |
| CN103301860A (zh) * | 2013-06-09 | 2013-09-18 | 常州大学 | 多壁碳纳米管负载磷酸银可见光光催化剂的制备方法 |
| CN110563990A (zh) * | 2019-09-17 | 2019-12-13 | 广西科技大学 | 具有光降解功能的含银纤维素复合材料的制备方法及其应用 |
| CN110743397A (zh) * | 2019-11-26 | 2020-02-04 | 天津工业大学 | 一种含磷酸银的海藻酸钙抗菌水凝胶过滤膜的制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| Exploitation of Ag3PO4 Impregnated Alginate Beads for the;Katnanipa Wanchai;《Key Engineering Materials》;20170822;第751卷;第689-694页 * |
| 立方体形Ag3PO4可见光光催化剂的制备及其性能研究;郭占云等;《陕西科技大学学报》;20130825;第31卷(第04期);第24-28页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112159552A (zh) | 2021-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Abdelgawad et al. | Antimicrobial wound dressing nanofiber mats from multicomponent (chitosan/silver-NPs/polyvinyl alcohol) systems | |
| CN106106522B (zh) | 一种纳米氧化锌-载银壳聚糖复合抗菌剂及其制备方法 | |
| JP2008231258A (ja) | セルロースエアロゲル及びその製造方法 | |
| Li et al. | Preparation and antibacterial activity of polyvinyl alcohol/regenerated silk fibroin composite fibers containing Ag nanoparticles | |
| CN111995799B (zh) | 一种纳米银/纤维素复合抗菌材料的制备方法 | |
| CN116479541A (zh) | 一种Cu-Zn-ZIF阻燃抗菌尼龙6复合纤维及其制备方法和应用 | |
| CN110204756B (zh) | 一种壳聚糖载银高强抗菌材料及其制备方法 | |
| CN116023408A (zh) | 一种纳米阻燃抑烟剂的制备及阻燃抑烟聚乳酸纤维材料 | |
| CN114832143A (zh) | 一种壳聚糖接枝漆酚/氧化石墨烯复合材料的制备方法 | |
| CN112159552B (zh) | 一种海藻多糖基磷酸银复合材料的制备方法 | |
| Li et al. | Preparation and characterization of PA/P (AA-co-AM) composite hydrogels via photopolymerization | |
| CN110016160A (zh) | 一种多糖基水凝胶的制备方法 | |
| CN110563990A (zh) | 具有光降解功能的含银纤维素复合材料的制备方法及其应用 | |
| CN112211005B (zh) | 一种难燃强抗菌的海洋多糖聚合物涂层材料 | |
| CN114230848A (zh) | 一种纳米氧化锌接枝聚苯乙烯复合泡沫板材料和制法 | |
| CN102352049B (zh) | 一种纳米贵金属粒子-纤维素杂化膜的制备方法 | |
| CN107441546A (zh) | 一种含银抗菌敷料的制备方法 | |
| CN107377992A (zh) | 利用羊毛角蛋白制备纳米银的方法 | |
| CN111996617B (zh) | 一种耐火抗菌海藻纤维的制作方法 | |
| CN105714397B (zh) | 一种纳米硫化亚铜/聚乙烯醇复合导电纤维的制备方法 | |
| CN116103782A (zh) | 一种阻燃抗菌尼龙6复合材料及其制备方法和应用 | |
| CN110343215A (zh) | 一种抗菌性高吸水树脂的制备方法 | |
| CN112281257B (zh) | 一种负载纳米氯化银的海洋纤维的制备方法 | |
| CN110359317A (zh) | 一种薄层纳米氢氧化物多功能保护剂及其制备方法和应用 | |
| CN101871137A (zh) | 非水溶性聚谷氨酸纤维及其制造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP02 | Change in the address of a patent holder | ||
| CP02 | Change in the address of a patent holder |
Address after: No. 308, Ningxia Road, Laoshan District, Qingdao, Shandong 266022 Patentee after: QINGDAO University Address before: No.308 Ningxia road, Shibei District, Qingdao City, Shandong Province 266022 Patentee before: QINGDAO University |
